HEADER TRANSFERASE 06-JUL-17 5WDY TITLE CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH 1-CYCLOHEXYL-N-({6-FLUORO-1- TITLE 2 [2-(3-METHOXYPHENYL)PYRIDIN-4-YL]-1H-INDOL-3-YL}METHYL)METHANAMINE TITLE 3 (COMPOUND 6) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE WNK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 206-483; COMPND 5 SYNONYM: ERYTHROCYTE 65 KDA PROTEIN, P65, KINASE DEFICIENT PROTEIN, COMPND 6 PROTEIN KINASE LYSINE-DEFICIENT 1, PROTEIN KINASE WITH NO LYSINE 1, COMPND 7 HWNK1; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WNK1, HSN2, KDP, KIAA0344, PRKWNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.XIE,D.KOHLS REVDAT 3 13-MAR-24 5WDY 1 LINK REVDAT 2 06-SEP-17 5WDY 1 JRNL REVDAT 1 16-AUG-17 5WDY 0 JRNL AUTH K.YAMADA,J.LEVELL,T.YOON,D.KOHLS,D.YOWE,D.F.RIGEL,H.IMASE, JRNL AUTH 2 J.YUAN,K.YASOSHIMA,K.DIPETRILLO,L.MONOVICH,L.XU,M.ZHU, JRNL AUTH 3 M.KATO,M.JAIN,N.IDAMAKANTI,P.TASLIMI,T.KAWANAMI,U.A.ARGIKAR, JRNL AUTH 4 V.KUNJATHOOR,X.XIE,Y.I.YAGI,Y.IWAKI,Z.ROBINSON,H.M.PARK JRNL TITL OPTIMIZATION OF ALLOSTERIC WITH-NO-LYSINE (WNK) KINASE JRNL TITL 2 INHIBITORS AND EFFICACY IN RODENT HYPERTENSION MODELS. JRNL REF J. MED. CHEM. V. 60 7099 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28771350 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00708 REMARK 2 REMARK 2 RESOLUTION. 2.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 17748 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 906 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.8459 - 4.4632 0.98 2897 164 0.1968 0.2352 REMARK 3 2 4.4632 - 3.5440 0.98 2900 160 0.1956 0.2668 REMARK 3 3 3.5440 - 3.0964 0.98 2887 156 0.2505 0.3369 REMARK 3 4 3.0964 - 2.8134 0.98 2881 154 0.2862 0.3532 REMARK 3 5 2.8134 - 2.6119 0.95 2819 148 0.3166 0.3535 REMARK 3 6 2.6119 - 2.4579 0.83 2458 124 0.3268 0.4091 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4401 REMARK 3 ANGLE : 0.783 5931 REMARK 3 CHIRALITY : 0.045 645 REMARK 3 PLANARITY : 0.003 728 REMARK 3 DIHEDRAL : 10.944 3175 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WDY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000228859. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17795 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.43300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLIZATION OF PROTEIN/COMPOUND REMARK 280 COMPLEX, RESERVOIR SOLUTION: 100 MM BIS-TRIS, PH 6.5, 20-25% REMARK 280 PEG3350, 150-300 MM MAGNESIUM FORMATE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 205 REMARK 465 GLU A 206 REMARK 465 LEU A 207 REMARK 465 VAL A 291 REMARK 465 LYS A 292 REMARK 465 GLY A 293 REMARK 465 LYS A 294 REMARK 465 LYS A 295 REMARK 465 ASP A 378 REMARK 465 PHE A 379 REMARK 465 ALA A 380 REMARK 465 LYS A 381 REMARK 465 SER A 382 REMARK 465 VAL A 383 REMARK 465 ILE A 384 REMARK 465 GLY A 385 REMARK 465 THR A 386 REMARK 465 GLU A 482 REMARK 465 THR A 483 REMARK 465 GLY B 205 REMARK 465 ASP B 254 REMARK 465 ARG B 255 REMARK 465 LYS B 256 REMARK 465 ALA B 377 REMARK 465 ASP B 378 REMARK 465 PHE B 379 REMARK 465 ALA B 380 REMARK 465 LYS B 381 REMARK 465 SER B 382 REMARK 465 VAL B 383 REMARK 465 ILE B 384 REMARK 465 GLY B 385 REMARK 465 VAL B 439 REMARK 465 LYS B 440 REMARK 465 PRO B 441 REMARK 465 ALA B 442 REMARK 465 GLU B 481 REMARK 465 GLU B 482 REMARK 465 THR B 483 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 233 O1A ANP A 901 2.11 REMARK 500 NZ LYS B 310 O HOH B 601 2.12 REMARK 500 OE1 GLU B 414 O HOH B 601 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 231 -73.95 -64.51 REMARK 500 GLN A 276 89.70 -165.12 REMARK 500 SER A 289 149.54 -173.09 REMARK 500 ARG A 348 -14.71 71.58 REMARK 500 ASP A 368 79.67 55.36 REMARK 500 GLU A 388 -60.96 -108.13 REMARK 500 ALA A 398 45.11 -90.57 REMARK 500 ASP A 400 -148.58 -147.54 REMARK 500 ARG B 229 114.25 -160.55 REMARK 500 PHE B 232 -30.63 -132.91 REMARK 500 THR B 234 88.13 -152.81 REMARK 500 THR B 244 43.22 35.31 REMARK 500 SER B 306 23.92 -78.95 REMARK 500 LYS B 317 -81.82 -127.52 REMARK 500 ARG B 348 -10.51 66.41 REMARK 500 ASP B 368 81.56 54.59 REMARK 500 LEU B 369 38.03 -95.94 REMARK 500 PHE B 389 49.57 -84.67 REMARK 500 ASP B 400 -158.99 -142.61 REMARK 500 SER B 437 -64.88 -91.19 REMARK 500 ASN B 475 36.86 -92.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 904 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 354 OD1 REMARK 620 2 ASP A 368 OD2 90.7 REMARK 620 3 ANP A 901 O1A 141.5 106.3 REMARK 620 4 HOH A1005 O 67.4 146.0 80.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B 501 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 354 OD1 REMARK 620 2 ANP B 502 O2A 144.9 REMARK 620 3 ANP B 502 O1G 115.8 99.2 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A6S A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MN A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MN A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MN B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A6S B 503 DBREF 5WDY A 206 483 UNP Q9H4A3 WNK1_HUMAN 206 483 DBREF 5WDY B 206 483 UNP Q9H4A3 WNK1_HUMAN 206 483 SEQADV 5WDY GLY A 205 UNP Q9H4A3 EXPRESSION TAG SEQADV 5WDY ASP A 378 UNP Q9H4A3 SER 378 ENGINEERED MUTATION SEQADV 5WDY ALA A 396 UNP Q9H4A3 GLU 396 ENGINEERED MUTATION SEQADV 5WDY ALA A 397 UNP Q9H4A3 GLU 397 ENGINEERED MUTATION SEQADV 5WDY ALA A 398 UNP Q9H4A3 LYS 398 ENGINEERED MUTATION SEQADV 5WDY GLY B 205 UNP Q9H4A3 EXPRESSION TAG SEQADV 5WDY ASP B 378 UNP Q9H4A3 SER 378 ENGINEERED MUTATION SEQADV 5WDY ALA B 396 UNP Q9H4A3 GLU 396 ENGINEERED MUTATION SEQADV 5WDY ALA B 397 UNP Q9H4A3 GLU 397 ENGINEERED MUTATION SEQADV 5WDY ALA B 398 UNP Q9H4A3 LYS 398 ENGINEERED MUTATION SEQRES 1 A 279 GLY GLU LEU GLU THR LYS ALA VAL GLY MET SER ASN ASP SEQRES 2 A 279 GLY ARG PHE LEU LYS PHE ASP ILE GLU ILE GLY ARG GLY SEQRES 3 A 279 SER PHE LYS THR VAL TYR LYS GLY LEU ASP THR GLU THR SEQRES 4 A 279 THR VAL GLU VAL ALA TRP CYS GLU LEU GLN ASP ARG LYS SEQRES 5 A 279 LEU THR LYS SER GLU ARG GLN ARG PHE LYS GLU GLU ALA SEQRES 6 A 279 GLU MET LEU LYS GLY LEU GLN HIS PRO ASN ILE VAL ARG SEQRES 7 A 279 PHE TYR ASP SER TRP GLU SER THR VAL LYS GLY LYS LYS SEQRES 8 A 279 CYS ILE VAL LEU VAL THR GLU LEU MET THR SER GLY THR SEQRES 9 A 279 LEU LYS THR TYR LEU LYS ARG PHE LYS VAL MET LYS ILE SEQRES 10 A 279 LYS VAL LEU ARG SER TRP CYS ARG GLN ILE LEU LYS GLY SEQRES 11 A 279 LEU GLN PHE LEU HIS THR ARG THR PRO PRO ILE ILE HIS SEQRES 12 A 279 ARG ASP LEU LYS CYS ASP ASN ILE PHE ILE THR GLY PRO SEQRES 13 A 279 THR GLY SER VAL LYS ILE GLY ASP LEU GLY LEU ALA THR SEQRES 14 A 279 LEU LYS ARG ALA ASP PHE ALA LYS SER VAL ILE GLY THR SEQRES 15 A 279 PRO GLU PHE MET ALA PRO GLU MET TYR ALA ALA ALA TYR SEQRES 16 A 279 ASP GLU SER VAL ASP VAL TYR ALA PHE GLY MET CYS MET SEQRES 17 A 279 LEU GLU MET ALA THR SER GLU TYR PRO TYR SER GLU CYS SEQRES 18 A 279 GLN ASN ALA ALA GLN ILE TYR ARG ARG VAL THR SER GLY SEQRES 19 A 279 VAL LYS PRO ALA SER PHE ASP LYS VAL ALA ILE PRO GLU SEQRES 20 A 279 VAL LYS GLU ILE ILE GLU GLY CYS ILE ARG GLN ASN LYS SEQRES 21 A 279 ASP GLU ARG TYR SER ILE LYS ASP LEU LEU ASN HIS ALA SEQRES 22 A 279 PHE PHE GLN GLU GLU THR SEQRES 1 B 279 GLY GLU LEU GLU THR LYS ALA VAL GLY MET SER ASN ASP SEQRES 2 B 279 GLY ARG PHE LEU LYS PHE ASP ILE GLU ILE GLY ARG GLY SEQRES 3 B 279 SER PHE LYS THR VAL TYR LYS GLY LEU ASP THR GLU THR SEQRES 4 B 279 THR VAL GLU VAL ALA TRP CYS GLU LEU GLN ASP ARG LYS SEQRES 5 B 279 LEU THR LYS SER GLU ARG GLN ARG PHE LYS GLU GLU ALA SEQRES 6 B 279 GLU MET LEU LYS GLY LEU GLN HIS PRO ASN ILE VAL ARG SEQRES 7 B 279 PHE TYR ASP SER TRP GLU SER THR VAL LYS GLY LYS LYS SEQRES 8 B 279 CYS ILE VAL LEU VAL THR GLU LEU MET THR SER GLY THR SEQRES 9 B 279 LEU LYS THR TYR LEU LYS ARG PHE LYS VAL MET LYS ILE SEQRES 10 B 279 LYS VAL LEU ARG SER TRP CYS ARG GLN ILE LEU LYS GLY SEQRES 11 B 279 LEU GLN PHE LEU HIS THR ARG THR PRO PRO ILE ILE HIS SEQRES 12 B 279 ARG ASP LEU LYS CYS ASP ASN ILE PHE ILE THR GLY PRO SEQRES 13 B 279 THR GLY SER VAL LYS ILE GLY ASP LEU GLY LEU ALA THR SEQRES 14 B 279 LEU LYS ARG ALA ASP PHE ALA LYS SER VAL ILE GLY THR SEQRES 15 B 279 PRO GLU PHE MET ALA PRO GLU MET TYR ALA ALA ALA TYR SEQRES 16 B 279 ASP GLU SER VAL ASP VAL TYR ALA PHE GLY MET CYS MET SEQRES 17 B 279 LEU GLU MET ALA THR SER GLU TYR PRO TYR SER GLU CYS SEQRES 18 B 279 GLN ASN ALA ALA GLN ILE TYR ARG ARG VAL THR SER GLY SEQRES 19 B 279 VAL LYS PRO ALA SER PHE ASP LYS VAL ALA ILE PRO GLU SEQRES 20 B 279 VAL LYS GLU ILE ILE GLU GLY CYS ILE ARG GLN ASN LYS SEQRES 21 B 279 ASP GLU ARG TYR SER ILE LYS ASP LEU LEU ASN HIS ALA SEQRES 22 B 279 PHE PHE GLN GLU GLU THR HET ANP A 901 31 HET A6S A 902 33 HET MN A 903 1 HET MN A 904 1 HET MN B 501 1 HET ANP B 502 31 HET A6S B 503 33 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM A6S 1-CYCLOHEXYL-N-({6-FLUORO-1-[2-(3-METHOXYPHENYL) HETNAM 2 A6S PYRIDIN-4-YL]-1H-INDOL-3-YL}METHYL)METHANAMINE HETNAM MN MANGANESE (II) ION FORMUL 3 ANP 2(C10 H17 N6 O12 P3) FORMUL 4 A6S 2(C28 H30 F N3 O) FORMUL 5 MN 3(MN 2+) FORMUL 10 HOH *33(H2 O) HELIX 1 AA1 SER A 260 LEU A 275 1 16 HELIX 2 AA2 THR A 308 LYS A 314 1 7 HELIX 3 AA3 LYS A 320 THR A 340 1 21 HELIX 4 AA4 ALA A 391 ALA A 398 1 8 HELIX 5 AA5 GLU A 401 SER A 418 1 18 HELIX 6 AA6 ASN A 427 SER A 437 1 11 HELIX 7 AA7 PRO A 441 VAL A 447 5 7 HELIX 8 AA8 ILE A 449 ILE A 460 1 12 HELIX 9 AA9 ASN A 463 ARG A 467 5 5 HELIX 10 AB1 SER A 469 ASN A 475 1 7 HELIX 11 AB2 LEU B 207 ALA B 211 5 5 HELIX 12 AB3 SER B 260 GLY B 274 1 15 HELIX 13 AB4 THR B 308 LYS B 314 1 7 HELIX 14 AB5 LYS B 320 THR B 340 1 21 HELIX 15 AB6 ALA B 391 ALA B 396 1 6 HELIX 16 AB7 GLU B 401 SER B 418 1 18 HELIX 17 AB8 ASN B 427 GLY B 438 1 12 HELIX 18 AB9 SER B 443 VAL B 447 5 5 HELIX 19 AC1 ILE B 449 GLY B 458 1 10 HELIX 20 AC2 ASN B 463 ARG B 467 5 5 HELIX 21 AC3 SER B 469 ASN B 475 1 7 SHEET 1 AA1 5 PHE A 220 ARG A 229 0 SHEET 2 AA1 5 THR A 234 ASP A 240 -1 O LEU A 239 N LEU A 221 SHEET 3 AA1 5 GLU A 246 LEU A 252 -1 O TRP A 249 N TYR A 236 SHEET 4 AA1 5 ILE A 297 GLU A 302 -1 O THR A 301 N ALA A 248 SHEET 5 AA1 5 PHE A 283 GLU A 288 -1 N TRP A 287 O VAL A 298 SHEET 1 AA2 2 ILE A 345 ILE A 346 0 SHEET 2 AA2 2 THR A 373 LEU A 374 -1 O THR A 373 N ILE A 346 SHEET 1 AA3 2 ILE A 355 THR A 358 0 SHEET 2 AA3 2 SER A 363 ILE A 366 -1 O LYS A 365 N PHE A 356 SHEET 1 AA4 6 GLY B 213 MET B 214 0 SHEET 2 AA4 6 PHE B 220 ARG B 229 -1 O LYS B 222 N GLY B 213 SHEET 3 AA4 6 THR B 234 ASP B 240 -1 O VAL B 235 N ILE B 227 SHEET 4 AA4 6 VAL B 245 LEU B 252 -1 O TRP B 249 N TYR B 236 SHEET 5 AA4 6 LYS B 295 GLU B 302 -1 O THR B 301 N ALA B 248 SHEET 6 AA4 6 PHE B 283 THR B 290 -1 N SER B 289 O CYS B 296 SHEET 1 AA5 2 ILE B 345 ILE B 346 0 SHEET 2 AA5 2 THR B 373 LEU B 374 -1 O THR B 373 N ILE B 346 SHEET 1 AA6 2 ILE B 355 THR B 358 0 SHEET 2 AA6 2 SER B 363 ILE B 366 -1 O LYS B 365 N PHE B 356 LINK OD1 ASN A 354 MN MN A 904 1555 1555 2.35 LINK OD2 ASP A 368 MN MN A 904 1555 1555 2.36 LINK O1A ANP A 901 MN MN A 904 1555 1555 2.60 LINK MN MN A 904 O HOH A1005 1555 1555 2.54 LINK OD1 ASN B 354 MN MN B 501 1555 1555 2.48 LINK MN MN B 501 O2A ANP B 502 1555 1555 2.44 LINK MN MN B 501 O1G ANP B 502 1555 1555 2.26 CISPEP 1 THR A 342 PRO A 343 0 -2.66 CISPEP 2 THR B 342 PRO B 343 0 0.29 SITE 1 AC1 9 GLY A 228 GLY A 230 SER A 231 LYS A 233 SITE 2 AC1 9 VAL A 235 GLU A 302 MET A 304 LYS A 351 SITE 3 AC1 9 MN A 904 SITE 1 AC2 11 PHE A 265 GLU A 268 ALA A 269 LEU A 272 SITE 2 AC2 11 VAL A 281 PHE A 283 LEU A 299 ASP A 368 SITE 3 AC2 11 LEU A 369 GLY A 370 ALA A 372 SITE 1 AC3 1 HOH A1007 SITE 1 AC4 4 ASN A 354 ASP A 368 ANP A 901 HOH A1005 SITE 1 AC5 3 ASN B 354 ASP B 368 ANP B 502 SITE 1 AC6 8 GLY B 230 LYS B 233 VAL B 235 GLU B 302 SITE 2 AC6 8 LEU B 303 MET B 304 ASP B 368 MN B 501 SITE 1 AC7 12 PHE B 265 GLU B 268 ALA B 269 LEU B 272 SITE 2 AC7 12 VAL B 281 PHE B 283 SER B 286 ASP B 368 SITE 3 AC7 12 LEU B 369 GLY B 370 ALA B 372 LEU B 374 CRYST1 34.334 62.267 70.268 67.13 77.42 74.74 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029126 -0.007945 -0.003955 0.00000 SCALE2 0.000000 0.016647 -0.006259 0.00000 SCALE3 0.000000 0.000000 0.015578 0.00000